Clinical study protocols continue to grow more complex, requiring larger capacity, specific patient populations, complex procedures and sample requirements, multiple endpoints, and flexible protocol design. At Covance these complex trial designs are a special focus for our clinical research units.
Your phase I Covance team of scientists and clinicians closely monitor clinical testing, including preliminary evaluation of drug safety, tolerance and pharmacokinetics. As more information on your drug candidate becomes available, we'll scrutinize development progress and deliver additional data for decisions including drug-drug interactions, food effect and special population studies.
Phase I studies and services: